1941: Innovations Forged in the Crucible of War

What You Will Learn

This article explores how, even during the years when the Nobel Prize was suspended, critical advancements in medicine—including large-scale blood transfusions, the clinical trials of penicillin, and protocols for burn care—were rapidly developed and refined in the field hospitals of wartime. It explains how this accelerated wartime medicine laid the groundwork for the Nuremberg Code and today’s Good Clinical Practice (GCP) guidelines.

Beyond the Pause: Unveiling the True Significance of the “Year the Nobel Prize Was Suspended”

When discussing the 1940-1942 period, it is often mistakenly assumed that “scientific progress stagnated during this time.” The reality is quite the opposite. This was a period of unprecedented rapid and, at times, brutal advancements in medicine. The key difference was that these developments occurred not in university laboratories, but in field hospitals on the front lines.

1941 was a pivotal year. The war expanded from a continental conflict to a global one. The German invasion of the Soviet Union in June (Operation Barbarossa) opened the Eastern Front, and the attack on Pearl Harbor in December brought the United States into the war, extending the conflict to the Pacific. The number of combatants, casualties, and areas with high infection risks increased dramatically, creating an unprecedented demand that could not be met by conventional peacetime medical protocols.

This article will examine the three accelerated cycles—blood transfusion, penicillin, and burn care—that emerged from this surge in demand, and the legacy they have left for us today.

The Shifting Landscape: A War Expanding Across the Globe

In 1941, the war transformed from a localized conflict into a full-fledged world war.

In March, the United States enacted the Lend-Lease Act, providing substantial military and material aid to Britain and the Soviet Union. Although not yet actively engaged in combat, this marked a crucial turning point as the United States began to support the Allied war effort. In May, the Battle of the Atlantic intensified, with German U-boats sinking a large number of supply ships bound for Britain. The logistical challenge of transporting plasma, penicillin, and blood transfusion equipment across the Atlantic became a strategic imperative.

On June 22nd, Nazi Germany invaded the Soviet Union. In the first six months, the Soviet Union suffered 2.6 million casualties. To cope with this massive influx of casualties, the Soviets established the world’s first large-scale mobile blood bank network. Led by Sergei Yudin, this system included the controversial practice of using blood collected from corpses in emergency situations, which later shocked the Western medical community.

On December 7th, Pearl Harbor. The attack brought the United States into the war, opening the Pacific theater. Tropical diseases (malaria, dengue fever, typhus) emerged as a new major source of casualties. The US Department of Defense invested unprecedented resources in the development of antimalarial drugs and insecticides, leading to the later development of DDT and atabrine.

In the context of Korean history, 1941 was the year the Joseon Language Society incident occurred. The effort to compile a Korean dictionary was forcibly suppressed, and scholars were arrested. While medical advancements were being rapidly developed on the battlefields of Europe and the Pacific, in Korea, scholars’ quiet resistance to preserve their language and culture was crushed. These two parallel trends—the accelerated pace of medical innovation driven by wartime demands, and the suppression of language and culture—defined the era.

Three Accelerated Cycles

Let’s use the concept of urgent patch deployments in software development as an analogy for the flow of wartime medicine. In peacetime, there is a multi-year cycle of development, testing, staging, and production. However, when a critical bug emerges in a live service, this cycle is compressed into a few weeks. This requires accepting the risk of insufficient testing and deploying the patch immediately. Wartime medicine in 1941 was precisely this type of accelerated cycle. The only difference was that the critical bugs were human lives, measured in tens of thousands per day.

Cycle 1: Charles Drew and the Blood Bank – The Birth of Large-Scale Distribution Infrastructure

Charles Drew was an African American surgeon trained at Columbia University. His doctoral thesis (1940) addressed a critical need of the era: “Banked Blood” – a system for the large-scale storage and distribution of blood.

Whole blood does not store well and has a limited shelf life. However, when plasma is separated, it can be stored at room temperature for several weeks and refrigerated for months. Furthermore, plasma does not require blood type matching. This means that it is possible to collect blood from a large number of donors in one area, process it, and transport it to the front lines. This concept is analogous to the producer-consumer architecture commonly used in databases today. Donors are the producers, plasma is the message stored in the queue, and wounded soldiers on the front lines are the consumers.

The “Blood for Britain” program led by Drew in New York between 1940 and 1941 was the first large-scale real-world deployment of this architecture. Over five months, 14,556 New York citizens donated blood, and more than 5,000 liters of plasma were shipped across the Atlantic to treat casualties of the London Blitz. This was the first international-scale blood bank system in human history.

In 1941, the American Red Cross appointed Drew to oversee the domestic expansion of this system. And here, a parallel story emerges. The US military and the Red Cross implemented a policy of separating and storing blood from Black donors and white donors, and administering white blood to white patients. This was a purely racist policy with no scientific basis. After repeated protests, Drew resigned. He spent the rest of his life training future Black surgeons at Howard University.

This analogy breaks down here. In a database’s producer-consumer architecture, there is no logical reason to tag data with race and route it differently. However, in human-designed systems, this seemingly illogical separation can be implemented in practice. The dark lesson from the 1941 blood bank story is that the technical elegance of a system does not automatically prevent the biases of its operators.

Cycle 2: Albert Alexander and the First Human Trial of Penicillin

The Oxford penicillin team successfully obtained purified penicillin in May 1940 (see the 1940 special). However, it was in February 1941 that they administered it to a human for the first time. The subject of this first clinical trial was Albert Alexander, a 43-year-old police officer from Oxford.

Alexander had been scratched on the face by a rose thorn while gardening, and the wound had become infected with Streptococcus bacteria, causing a severe, life-threatening infection that had cost him one eye. In the pre-antibiotic era, even minor injuries could lead to death from infection. The Oxford team administered penicillin to Alexander intravenously.

Dramatic improvement began within 24 hours. His fever subsided, the infected tissue began to heal, and Alexander began to eat again. It was the moment humanity witnessed the first clinical power of antibiotics.

However, the supply of penicillin was limited. The Oxford team had only enough penicillin to treat Alexander for a few days. They even attempted to recycle the penicillin by extracting it from Alexander’s urine and re-administering it. However, the supply ran out. Five days later, Alexander died of a recurrence of the infection.

This failure was crucial. It demonstrated that penicillin was clinically effective, but it also highlighted the lack of large-scale production capacity. The Oxford team used these results to approach the industrial capacity of the United States. This led to the establishment of large-scale fermentation processes in Peoria, Illinois, in 1942-1943, which ultimately led to the 1945 Nobel Prize.

In terms of software development, the Alexander case was the first production deployment. It validated that the hotfix worked as expected, but it also revealed that the product’s production capacity could not meet the demand. The subsequent focus shifted to scaling the production. This is the cycle that medical R&D continues to repeat today: Phase 1 success, Phase 3 scale failure, and then industrialization.

Cycle 3: Battle of Britain Pilots – Real-World Refactoring of Burn Care Protocols

In the Battle of Britain (July-October 1940), the leading cause of death for RAF pilots who were shot down was third-degree burns to the face and hands. In particular, burns to the hands were a major problem; when pilots with hand burns were brought to the hospital, their hands were often beyond saving because they had been unable to release the controls.

In response to this crisis, Archibald McIndoe developed a completely new burn care protocol at the hospital in East Grinstead.

McIndoe, a New Zealand-born plastic surgeon, observed that the existing protocol of applying tannic acid to wounds was actually a breeding ground for infection, and that the resulting scab caused tissue death underneath. He replaced this protocol with saline baths, a method of gently cleaning the burned area with warm salt water, removing dead tissue, and then performing multi-stage skin grafts.

At the same time, he created the “Guinea Pig Club”, a support group for burn victims. Instead of isolating the pilots with disfigured faces, he regularly exposed them to the community, making social reintegration an integral part of the clinical protocol. This approach is the early prototype of what we know today as rehabilitation medicine and the integration of psychosocial care.

The analogy to refactoring is clear. What McIndoe did was precisely a refactoring of a legacy protocol. The previous burn care method (tannic acid) was the accepted practice of the time, but after observing its negative effects in real-world deployments, he fundamentally redesigned the system. And refactoring was not just about changing the algorithm. He included the patient’s social life as part of the system’s interface. Today’s software developers talk about designing for “experiences, not just products,” and this principle was already being practiced at this hospital.

The Nuremberg Code and its Prelude

The accelerated cycles of wartime medicine in 1941 also cast a dark shadow. It was also a time when the social system for reviewing medical experiments completely broke down.

In 1941, Nazi concentration camps saw the beginning of large-scale human experimentation. Experiments on hypothermia, low-pressure environments, and infectious diseases were conducted in camps such as Dachau and Auschwitz. The Japanese Unit 731 also reached its peak in Manchuria during this period. The United States continued the Tuskegee Study, in which Black men were used as subjects for an untreated syphilis study, throughout this period.

The accelerated cycles of wartime medicine in 1941 involved both approaches: the explicit consent and benefit-oriented approach, as seen in the Alexander case, and the approach that treated patients solely as experimental subjects, as seen in the Nazi, Unit 731, and Tuskegee experiments. As the contrast between these two trends became more pronounced, the question of “Is patient autonomy and consent a prerequisite for medicine?” became increasingly pressing within the medical community.

This pressure led to the Nuremberg Code in 1947, the Declaration of Helsinki in 1964, and today’s Good Clinical Practice (GCP) guidelines. Thus, the three principles that we require in clinical trials today—informed consent, independent review, and patient benefit—are a direct response to the dark events of this period. This is the seed of the story that will be continued in the 1942 special.

Why It Matters

The legacy of wartime medicine in 1941 consists of three legacies and one question.

The three legacies are still the foundation of our hospitals today. The blood bank system is quietly operating behind the emergency rooms of all major hospitals today. The penicillin mass-production is the ancestor of all antibiotics today, and we live in its shadow. McIndoe’s burn protocol is still the standard in burn centers today, and the concepts of rehabilitation medicine and social reintegration are still evolving.

The one question remains unanswered. “How much can we compress testing when there is an emergency?” The rapid approval of mRNA vaccines in 2020 during the COVID-19 pandemic was another example of this question in modern times. While the compressed testing ultimately proved to be safe and effective, the question of how much trust we should place in this compression remains a subject of debate. It is important to remember that the Alexander case of 1941 and the mRNA vaccine of 2020 are asking us the same question.

Even though the Nobel Prize system was suspended in 1941, medicine was quietly creating the future not on the stage of award ceremonies, but in field hospitals. That quiet compression is what created us today.

Summary of 1941 Wartime Medicine: Three accelerated cycles—blood bank (Charles Drew), first human trial of penicillin (Alexander case), and burn care protocol (McIndoe)—were developed in real-world settings, while the dark shadow of the Nazi human experiments and Tuskegee experiments unfolded in parallel, ultimately leading to the inevitable Nuremberg Code (1947).

→ Previous: 1940: The Year the Nobel Prize Was Suspended → Next: 1942: The Boundary Between Ethics and Science